| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
ATHENS, Ga.—In developing vaccines against various cancers, researchers would like to take advantage of the aberrant saccharide or glycopeptides signatures of tumor cells. Unfortunately, because these sugars are self-antigens, they elicit poor B-cell responses that are easily swamped by the body's reaction to the carbohydrate carrier proteins like BSA. Recently, researchers at the University of Georgia developed a tripartite vaccine that overcomes these problems.
 
As they describe in Nature Chemical Biology, the researchers synthesized vaccine candidates comprised of tumor-associated carbohydrate B epitopes, promiscuous peptide T-helper (Th) epitopes, and Toll-like receptor (TLR) ligands. Using microtiter assays and flow cytometry, they noted that immunized mice showed high IgG titers against the sugar (MUC1) but not the Th epitope, suggesting they had solved the carrier-induced immune suppression.
 
The researchers also noted that the candidates induced strong cytokine responses, facilitating immune cell maturation. Furthermore, the TLR ligands greatly facilitated uptake by antigen-presenting cells (APCs), which assists with antigen processing and full activation.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

GreenCooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue